Literature DB >> 26379993

Posterior reversible encephalopathy syndrome following paroxysmal nocturnal hemoglobinuria: a case report and literature review.

Dongxue Ding1, Kai Li1, Guoliang Li1, Xiaoyan Long1.   

Abstract

Paroxysmal nocturnal hemoglobinuria (PNH) is a rare acquired disorder characterized by hemolytic anemia, marrow failure, and a high incidence of life-threatening venous thrombosis. It is subject to a considerable variety of complications like intestinal obstruction and visceral embolism. The current study firstly presents a 40-year-old male with a previous diagnosis of PNH who developed posterior reversible encephalopathy syndrome (PRES) during treatment with methylprednisolone. He was referred to our department with headache and two episodes of generalized tonic-clonic seizures. Laboratory examination revealed peripheral blood cytopenias and elevated count of reticulocyte. Brain magnetic resonance imaging (MRI) exhibited abnormal signal in the bilateral parieto-occipital lobes with symmetric distribution which confirmed the diagnosis of PRES. After receive treatment of dexamethasone, anti-hypertensive and neurotropic drugs, the patient made a complete clinical recovery; and the abnormal signals of MRI were almost completely absorbed. This case shows that PRES might be a rare complication of PNH. Furthermore, it points out the necessity of rapid diagnosis and treatment of PRES.

Entities:  

Keywords:  Paroxysmal nocturnal hemoglobinuria; magnetic resonance imaging; methylprednisolone; posterior reversible encephalopathy syndrome; seizures

Year:  2015        PMID: 26379993      PMCID: PMC4565376     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  17 in total

Review 1.  Tacrolimus-associated posterior reversible encephalopathy syndrome after solid organ transplantation.

Authors:  Qisi Wu; Christian Marescaux; Valérie Wolff; Mi-Young Jeung; Romain Kessler; Valérie Lauer; Yangmei Chen
Journal:  Eur Neurol       Date:  2010-08-12       Impact factor: 1.710

Review 2.  Childhood posterior reversible encephalopathy syndrome.

Authors:  Bláthnaid McCoy; Mary King; Denis Gill; Eilish Twomey
Journal:  Eur J Paediatr Neurol       Date:  2010-11-11       Impact factor: 3.140

Review 3.  Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasogenic edema.

Authors:  W S Bartynski
Journal:  AJNR Am J Neuroradiol       Date:  2008-04-10       Impact factor: 3.825

4.  PRES: posterior or potentially reversible encephalopathy syndrome?

Authors:  M C Narbone; R Musolino; F Granata; I Mazzù; M Abbate; E Ferlazzo
Journal:  Neurol Sci       Date:  2006-07       Impact factor: 3.307

Review 5.  Paroxysmal nocturnal hemoglobinuria.

Authors:  Robert A Brodsky
Journal:  Blood       Date:  2014-09-18       Impact factor: 22.113

6.  Improving cytopenia with splenic artery embolization in a patient with paroxysmal nocturnal hemoglobinuria on eculizumab.

Authors:  Suresh K Krishnan; Anita Hill; Peter Hillmen; Louise M Arnold; Gemma L Brooksbank; Alex Wood; Andrew Scarsbrook; Mervyn H Davies; Richard J Kelly
Journal:  Int J Hematol       Date:  2013-10-25       Impact factor: 2.490

7.  Clinical spectrum of reversible posterior leukoencephalopathy syndrome.

Authors:  S Kwon; J Koo; S Lee
Journal:  Pediatr Neurol       Date:  2001-05       Impact factor: 3.372

Review 8.  Posterior reversible encephalopathy syndrome: an emerging clinical entity in adult, pediatric, and obstetric critical care.

Authors:  Heather O'Hara McCoy
Journal:  J Am Acad Nurse Pract       Date:  2008-02

9.  Posterior reversible encephalopathy syndrome: an acute manifestation of systemic lupus erythematous.

Authors:  Dexter Yak Seng Chan; Yin Sheng Ong
Journal:  Singapore Med J       Date:  2013-09       Impact factor: 1.858

10.  Delayed duodenal obstruction after intramural hematoma in a patient with paroxysmal nocturnal hemoglobinuria: A case report.

Authors:  Tugan Tezcaner; Yahya Ekici; Mahir Kırnap; Feride Kural; Gökhan Moray
Journal:  Int J Surg Case Rep       Date:  2014-07-24
View more
  1 in total

1.  Cerebrovascular manifestations in hematological diseases: an update.

Authors:  José M Ferro; Joana Infante
Journal:  J Neurol       Date:  2021-02-13       Impact factor: 4.849

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.